How does metabolic activity of a tumor affect PET scan results?

How does metabolic activity of a tumor affect PET scan results?

• A. Higher metabolic activity leads to less tracer uptake.
• B. Higher metabolic activity leads to more tracer uptake.
• C. It has no effect.
• D. Lower metabolic activity is preferred.

Answer: (B)

The metabolic activity of a tumor significantly influences the results of a PET scan because PET imaging relies on the uptake of radiotracers, commonly fluorodeoxyglucose (FDG), which is a glucose analog. Tumors with higher metabolic activity tend to consume more glucose compared to normal tissues, resulting in increased uptake of the radiotracer. As a result, when a PET scan is performed, regions of the body with higher metabolic activity, such as aggressive tumors, will show more intense areas of uptake on the imaging. This characteristic is vital for identifying and evaluating cancerous tissues, as it helps differentiate malignant tumors from benign conditions. Therefore, understanding the relationship between metabolic activity and tracer uptake is essential for interpreting PET scan results accurately and making informed clinical decisions regarding diagnosis and treatment planning.

The metabolic activity of a tumor significantly influences the results of a PET scan because PET imaging relies on the uptake of radiotracers, commonly fluorodeoxyglucose (FDG), which is a glucose analog. Tumors with higher metabolic activity tend to consume more glucose compared to normal tissues, resulting in increased uptake of the radiotracer. As a result, when a PET scan is performed, regions of the body with higher metabolic activity, such as aggressive tumors, will show more intense areas of uptake on the imaging.

This characteristic is vital for identifying and evaluating cancerous tissues, as it helps differentiate malignant tumors from benign conditions. Therefore, understanding the relationship between metabolic activity and tracer uptake is essential for interpreting PET scan results accurately and making informed clinical decisions regarding diagnosis and treatment planning.